News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity The enhanced benefits seen for those with higher BMIs is in sync with growing interest in obesity-related HF. L.A. McKeown December 13, 2024
Presentation AHA 2024 Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks Presenter: Steven E. Nissen November 18, 2024
Presentation AHA 2024 Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial Presenter: Marcely Gimenes Bonatto November 18, 2024
Presentation AHA 2024 OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial Presenter: Kausik K. Ray November 17, 2024
Presentation AHA 2024 Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial Presenter: Milton Packer November 16, 2024
Presentation TCT 2024 TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk Presenter: Ryo Hikida October 29, 2024
News Daily News Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity By L.A. McKeown December 23, 2024
News Daily News Alcohol’s Harms Last Beyond Active Binge Drinking: MunichBREW II By Caitlin E. Cox December 23, 2024
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back By Todd Neale December 19, 2024